Back to top

Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley

Morgan Stanley resumed coverage of Lakefront Biotherapeutics (LKFT) with an Equal Weight rating and $30 price target after the recent closing of th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)

Lakefront Biotherapeutics - Sponsored ADR (LKFT)